1: Zhang N, Gordon ML. Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients. Clin Interv Aging. 2018 Oct 11;13:1963-1970. doi: 10.2147/CIA.S159920. PMID: 30349215; PMCID: PMC6187917.
2: Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R. Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis. Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10. PMID: 32914577; PMCID: PMC7667299.
3: Govind N. Donepezil for dementia due to Alzheimer's disease. Br J Community Nurs. 2020 Mar 2;25(3):148-149. doi: 10.12968/bjcn.2020.25.3.148. PMID: 32160022.
4: Kawashiri T, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe T. Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a neuroprotective effect. J Pharmacol Sci. 2019 Jul;140(3):291-294. doi: 10.1016/j.jphs.2019.05.009. Epub 2019 Jul 19. PMID: 31377017.
5: Zhang X, Lian S, Zhang Y, Zhao Q. Efficacy and safety of donepezil for mild cognitive impairment: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2022 Feb;213:107134. doi: 10.1016/j.clineuro.2022.107134. Epub 2022 Jan 19. PMID: 35078087.
6: Adelman M, Louis L. A Novel Formulation: Donepezil Patch. Sr Care Pharm. 2023 Jul 1;38(7):300-304. doi: 10.4140/TCP.n.2023.300. PMID: 37381137.
7: Bago Rožanković P, Rožanković M, Badžak J, Stojić M, Šušak Sporiš I. Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study. Cogn Behav Neurol. 2021 Dec 2;34(4):288-294. doi: 10.1097/WNN.0000000000000285. PMID: 34851866.
8: Barfejani AH, Jafarvand M, Seyedsaadat SM, Rasekhi RT. Donepezil in the treatment of ischemic stroke: Review and future perspective. Life Sci. 2020 Dec 15;263:118575. doi: 10.1016/j.lfs.2020.118575. Epub 2020 Oct 12. PMID: 33058916.
9: Mezeiova E, Chalupova K, Nepovimova E, Gorecki L, Prchal L, Malinak D, Kuca K, Soukup O, Korabecny J. Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease. Curr Alzheimer Res. 2019;16(9):772-800. doi: 10.2174/1567205016666190228122956. PMID: 30819078.
10: Zhao ZQ, Chen BZ, Zhang XP, Zheng H, Guo XD. An Update on the Routes for the Delivery of Donepezil. Mol Pharm. 2021 Jul 5;18(7):2482-2494. doi: 10.1021/acs.molpharmaceut.1c00290. Epub 2021 Jun 8. PMID: 34100291.
11: Saeedi M, Mehranfar F. Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease. Recent Pat Biotechnol. 2022;16(2):102-121. doi: 10.2174/1872208316666220302115901. PMID: 35236274.
12: Takada-Takatori Y. [Donepezil Reduces Amyloid Precursor Protein Endocytosis by Resulting from Increase in the Expression of Sorting Nexin Protein 33]. Yakugaku Zasshi. 2021;141(6):851-856. Japanese. doi: 10.1248/yakushi.20-00251-6. PMID: 34078793.
13: Rong X, Jiang L, Qu M, Hassan SSU, Liu Z. Enhancing Therapeutic Efficacy of Donepezil by Combined Therapy: A Comprehensive Review. Curr Pharm Des. 2021;27(3):332-344. doi: 10.2174/1381612826666201023144836. PMID: 33100197.
14: Brewster JT 2nd, Dell'Acqua S, Thach DQ, Sessler JL. Classics in Chemical Neuroscience: Donepezil. ACS Chem Neurosci. 2019 Jan 16;10(1):155-167. doi: 10.1021/acschemneuro.8b00517. Epub 2018 Nov 8. PMID: 30372021.
15: Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease. Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6. PMID: 33035532.
16: Fang X, Zhang J, Zhao J, Wang L. Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease. J Healthc Eng. 2022 Mar 25;2022:9148650. doi: 10.1155/2022/9148650. Retraction in: J Healthc Eng. 2023 Jan 25;2023:9834320. PMID: 35368930; PMCID: PMC8975642.
17: Rajput A, Butani S. Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study. AAPS PharmSciTech. 2022 Feb 11;23(2):74. doi: 10.1208/s12249-022-02209-9. PMID: 35149912.
18: Kho J, Ioannou A, Mandal AKJ, Missouris CG. Donepezil induces ventricular arrhythmias by delayed repolarisation. Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar;394(3):559-560. doi: 10.1007/s00210-020-02028-4. Epub 2020 Nov 24. PMID: 33230575.
19: A donepezil patch (Adlarity) for Alzheimer's disease. Med Lett Drugs Ther. 2022 Aug 8;64(1656):e128-e129. PMID: 35921079.
20: Gao BL, Che NN, Li X, Ren CF. Neuroprotective effects of donepezil against Aβ25-35-induced neurotoxicity. Eur J Med Res. 2022 Oct 28;27(1):219. doi: 10.1186/s40001-022-00862-1. PMID: 36307893; PMCID: PMC9617393.